Literature DB >> 15161901

Aspirin and breast cancer prevention: the estrogen connection.

Raymond N DuBois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15161901     DOI： 10.1001/jama.291.20.2488

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.

Authors:  Louise R Howe; Scott M Lippman
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506

2.  Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.

Authors:  Tengteng Wang; Lauren E McCullough; Alexandra J White; Patrick T Bradshaw; Xinran Xu; Yoon Hee Cho; Mary Beth Terry; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Jia Chen; Marilie D Gammon
Journal:  Cancer       Date:  2019-08-12       Impact factor: 6.860

3.  Regular aspirin use and breast cancer risk in US Black women.

Authors:  Jaclyn L F Bosco; Julie R Palmer; Deborah A Boggs; Elizabeth E Hatch; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2011-08-30       Impact factor: 2.506

4.  Circulating levels of inflammatory markers and mammographic density among postmenopausal women.

Authors:  Katherine W Reeves; Joel L Weissfeld; Francesmary Modugno; Brenda Diergaarde
Journal:  Breast Cancer Res Treat       Date:  2010-11-11       Impact factor: 4.872

5.  Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort.

Authors:  Kunlanat Makboon; Ellen B Gold; Danielle J Harvey; Lesley M Butler; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2015-01-21       Impact factor: 2.506

6.  Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study.

Authors:  Lauren M Hurwitz; Aladdin H Shadyab; Fred K Tabung; Garnet L Anderson; Nazmus Saquib; Robert B Wallace; Robert A Wild; Ruth M Pfeiffer; Xia Xu; Britton Trabert
Journal:  Cancer Prev Res (Phila)       Date:  2022-03-01

Review 7.  Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  ScientificWorldJournal       Date:  2011-10-27

8.  Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Mary Beth Terry; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

9.  Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer.

Authors:  Xiaoke Liu; Lingzhi Hong; Monique Nilsson; Shawna Marie Hubert; Shuhong Wu; Waree Rinsurongkawong; Jeffery Lewis; Amy Spelman; Jack Roth; Steven Swisher; Yong He; J Jack Lee; Bingliang Fang; John V Heymach; Jianjun Zhang; Xiuning Le
Journal:  Lung Cancer       Date:  2020-09-09       Impact factor: 5.705

10.  Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial.

Authors:  S M Zhang; N R Cook; J E Manson; I-M Lee; J E Buring
Journal:  Br J Cancer       Date:  2008-02-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.